Arnaud M. Didierlaurent

Author

Also Known As

A DIDIER-LAURENT, A DIDIERLAURENT, A Didier-Laurent, A Didierlaurent, A M Didierlaurent, A. Didier-Laurent, A. Didierlaurent, A.M. Didierlaurent, ARNAUD DIDIERLAURENT, Andersen, Svein R.

129

Publications

8.7K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (Belgium)University of Geneva Université Libre de Bruxelles University Hospital of Geneva Inserm

About

Arnaud M. Didierlaurent is an author at GlaxoSmithKline (Belgium) specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	2.5K
2	Cell Biology	6	6	1K
3	Allergy	4	4	1.3K
4	Epidemiology	3	3	294
5	Public Health	1	1	127

Arnaud M. Didierlaurent

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity Arnaud M. Didierlaurent, Sandra Morel, Laurence Lockman, The Journal of Immunology Adaptive Immune SystemInnate Immune SystemImmunologyImmunologic MechanismCd4 T Cell Responses	2009	732
Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity Sandra Morel, Arnaud M. Didierlaurent, Patricia Bourguignon, Vaccine InflammationAllergyAdjuvant System As03α-Tocopherol ModulatesAdaptive Immune System	2011	462
A critical function for CD200 in lung immune homeostasis and the severity of influenza infection Robert J. Snelgrove, John Goulding, Arnaud M. Didierlaurent, Nature Immunology Influenza InfectionLung InflammationImmunologyRespiratory InfectionLung Immune Homeostasis	2008	461
Sustained desensitization to bacterial Toll-like receptor ligands after resolutionof respiratory influenza infection Arnaud M. Didierlaurent, John Goulding, Seema R. Patel, The Journal of Experimental Medicine	2008	389
Flagellin Promotes Myeloid Differentiation Factor 88-Dependent Development of Th2-Type Response Arnaud M. Didierlaurent, Isabel Ferrero, L. Otten, The Journal of Immunology	2004	311
Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells Arnaud M. Didierlaurent, Catherine Collignon, Patricia Bourguignon, The Journal of Immunology	2014	254
Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity Margherita Coccia, Catherine Collignon, Caroline Hervé, npj Vaccines	2017	236
Tollip Regulates Proinflammatory Responses to Interleukin-1 and Lipopolysaccharide Arnaud M. Didierlaurent, Brian Brissoni, Dominique Velin, Molecular and Cellular Biology	2006	199
An antiinflammatory role for IKKβ through the inhibition of “classical” macrophage activation Carol Ho-Yan Fong, Magali Bébien, Arnaud M. Didierlaurent, The Journal of Experimental Medicine Lung InflammationInnate Immune SystemImmunologyImmune RegulationInnate Immunity	2008	198
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study Arnaud G. L’Huillier, Benjamin Meyer, Diego O. Andrey, Clinical Microbiology and Infection Prospective Longitudinal StudyViral PersistenceAntibody PersistenceCovid-19 PandemicImmunology	2021	154

Page 1